triiodothyronine has been researched along with Disease Exacerbation in 58 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association between nonalcoholic fatty liver disease (NAFLD) and free triiodothyronine (FT3) in euthyroid subjects was in dispute." | 5.51 | Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. ( Bao, Y; Chen, P; Feng, L; Hou, X; Jia, W; Jiao, L; Wang, H; Wei, L; Zhong, L, 2019) |
| " Patients with overt or subclinical hypothyroidism should be treated with levothyroxine to improve their cardiovascular function and the potential risk of heart failure." | 5.01 | The Management of Thyroid Abnormalities in Chronic Heart Failure. ( Biondi, B, 2019) |
| "Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation." | 4.88 | Mechanisms in endocrinology: Heart failure and thyroid dysfunction. ( Biondi, B, 2012) |
| "Subclinical hypothyroidism is defined as normal serum free thyroxine and tri-iodothyronine concentrations and a slightly eleveted serum thyrotropin (TSH) concentration." | 4.82 | [Subclinical hypothyroidism]. ( Corvilain, B; Heureux, M, 2004) |
| " The parameters assessed were periodontitis-related bone loss, quality of tooth-supporting alveolar bone and the number of cells positive for tartrate-resistant acid phosphatase (TRAP), a marker of bone resorption." | 3.75 | The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats. ( Casati, MZ; de Toledo, S; Feitosa, DS; Marques, MR; Nociti, FH; Sallum, EA, 2009) |
| "To examine the natural history of a subnormal serum thyroid-stimulating hormone (TSH) concentration with normal concentrations of both serum free thyroxine (FT4) and free triiodothyronine (FT3) (subclinical hyperthyroidism)." | 3.73 | Observations concerning the natural history of subclinical hyperthyroidism. ( Woeber, KA, 2005) |
| "Different rat and mouse models of hepatocarcinogenesis were investigated." | 1.56 | Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming. ( Bellomo, SE; Cabras, L; Columbano, A; Follenzi, A; Fornari, F; Giordano, S; Gramantieri, L; Kowalik, MA; Ledda-Columbano, GM; Merlin, S; Morandi, A; Orrù, C; Parri, M; Perra, A; Petrelli, A; Puliga, E; Rasola, A; Sanchez-Martin, C; Sebastian, C; Sulas, P, 2020) |
| "THs are involved in a crosstalk between hepatoma and stromal cells, and disruption of TH signaling is associated with tumorigenesis." | 1.56 | Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression. ( Lin, KH; Wu, CH; Yeh, CT, 2020) |
| "Papillary thyroid cancer (80% of thyroid cancer) whose incidence is increasing worldwide, is associated with Hashimoto's thyroiditis." | 1.51 | A model of the cost of delaying treatment of Hashimotos thyroiditis: thyroid cancer initiation and growth. ( Merrill, SJ; Pandiyan, B, 2019) |
| "The association between nonalcoholic fatty liver disease (NAFLD) and free triiodothyronine (FT3) in euthyroid subjects was in dispute." | 1.51 | Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. ( Bao, Y; Chen, P; Feng, L; Hou, X; Jia, W; Jiao, L; Wang, H; Wei, L; Zhong, L, 2019) |
| "Whether D3 induction occurs in dilated cardiomyopathy is unknown." | 1.46 | Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy. ( Dorfman, DM; Huang, SA; Jay, PY; Jugo, RH; Maynard, MA; Padera, RF; Wassner, AJ; Zavacki, AM, 2017) |
| "Moreover, hyperinsulinemia reduces the circulating level of serum T4 and conversion of T4 to T3, mimicking hypothyroidism, because thyroid hormones are necessary for the maturation of chondrocytes." | 1.46 | Serum insulin in pathogenesis and treatment of osteoarthritis. ( Askari, A; Bahramali, E; Ehrampoush, E; Farjam, M; Homayounfar, R, 2017) |
| "The effects of miR-130b on hepatocellular carcinoma (HCC) invasion were further examined in vitro and in vivo." | 1.42 | Repression of microRNA-130b by thyroid hormone enhances cell motility. ( Chen, CY; Chen, WJ; Chi, HC; Chung, IH; Huang, YH; Liao, CJ; Lin, KH; Lin, TP; Lin, YH; Tsai, CY; Tsai, MM; Tseng, YH; Wu, MH; Wu, SM; Yeh, YH, 2015) |
| "After sepsis was cured, there was no hormonal change, except in 3 NT." | 1.42 | Nonthyroidal illnesses syndrome in full-term newborns with sepsis. ( Araujo, MC; Carvalho, WB; Ceccon, ME; Diniz, EM; Silva, MH, 2015) |
| "Triiodothyronine (T3) is a potent form of thyroid hormone mediates several physiological processes including cellular growth, development, and differentiation via binding to the nuclear thyroid hormone receptor (TR)." | 1.39 | Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4. ( Chen, CY; Chen, WJ; Chi, HC; Chung, IH; Huang, YH; Liao, CH; Liao, CJ; Lin, KH; Lin, YH; Tsai, CY; Tseng, YH; Wu, SM; Wu, TI, 2013) |
| "Nonautoimmune primary hyperthyroidism was diagnosed, and brain magnetic resonance imaging and computed tomography showed also Arnold-Chiari malformation type I." | 1.36 | Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy. ( Bertalan, R; Kovács, B; Lotz, G; Patócs, A; Rácz, K; Sallai, A; Sólyom, J; Szabó, E; Szabó, I, 2010) |
| "The development of Graves' disease (GD) from Hashimoto's thyroiditis (HT) has sporadically been reported, but no data are available concerning the prevalence of this sequence of events in GD patients." | 1.36 | Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease. ( Arrigo, T; Corrias, A; De Luca, F; Lombardo, F; Mussa, A; Salerno, M; Vigone, MC; Wasniewska, M, 2010) |
| "In chronic renal failure (CRF), dietary protein is one of the factors that deteriorates residual renal functions." | 1.33 | Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats. ( Inui, K; Ji, L; Masuda, S; Nishihara, K; Okuda, M; Shimizu, Y, 2005) |
| "The thyroid nodule was preoperatively evaluated with blood chemistry, ultrasound, nuclear scanning and FNAC." | 1.33 | Clinical importance of solitary solid nodule of the thyroid in endemic goiter region. ( Aslaner, A; Coskun, O; Gurleyik, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (6.90) | 18.2507 |
| 2000's | 24 (41.38) | 29.6817 |
| 2010's | 25 (43.10) | 24.3611 |
| 2020's | 5 (8.62) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y | 1 |
| Wang, Z | 1 |
| Liu, X | 1 |
| Wei, L | 2 |
| Li, S | 1 |
| Zheng, X | 1 |
| Yang, T | 1 |
| Xu, X | 1 |
| Pandiyan, B | 1 |
| Merrill, SJ | 1 |
| Kowalik, MA | 1 |
| Puliga, E | 1 |
| Cabras, L | 1 |
| Sulas, P | 1 |
| Petrelli, A | 1 |
| Perra, A | 1 |
| Ledda-Columbano, GM | 1 |
| Morandi, A | 1 |
| Merlin, S | 1 |
| Orrù, C | 1 |
| Sanchez-Martin, C | 1 |
| Fornari, F | 1 |
| Gramantieri, L | 1 |
| Parri, M | 1 |
| Rasola, A | 1 |
| Bellomo, SE | 1 |
| Sebastian, C | 1 |
| Follenzi, A | 1 |
| Giordano, S | 1 |
| Columbano, A | 1 |
| Huang, Y | 1 |
| Feng, L | 2 |
| Li, X | 1 |
| Huang, S | 1 |
| Deng, Y | 1 |
| Liang, ZE | 1 |
| Xia, N | 1 |
| Yang, Z | 1 |
| Pace, C | 1 |
| Tumino, D | 1 |
| Russo, M | 1 |
| Le Moli, R | 1 |
| Naselli, A | 1 |
| Borzì, G | 1 |
| Malandrino, P | 1 |
| Frasca, F | 1 |
| Wu, CH | 1 |
| Yeh, CT | 2 |
| Lin, KH | 4 |
| Wassner, AJ | 1 |
| Jugo, RH | 1 |
| Dorfman, DM | 1 |
| Padera, RF | 1 |
| Maynard, MA | 1 |
| Zavacki, AM | 1 |
| Jay, PY | 1 |
| Huang, SA | 1 |
| Popławski, P | 1 |
| Piekiełko-Witkowska, A | 1 |
| Nauman, A | 1 |
| Chen, P | 1 |
| Hou, X | 1 |
| Zhong, L | 1 |
| Jiao, L | 1 |
| Wang, H | 1 |
| Bao, Y | 1 |
| Jia, W | 1 |
| Biondi, B | 2 |
| Chi, HC | 3 |
| Liao, CH | 1 |
| Huang, YH | 3 |
| Wu, SM | 3 |
| Tsai, CY | 3 |
| Liao, CJ | 2 |
| Tseng, YH | 2 |
| Lin, YH | 2 |
| Chen, CY | 3 |
| Chung, IH | 2 |
| Wu, TI | 1 |
| Chen, WJ | 2 |
| Lee, HS | 1 |
| Hwang, JS | 1 |
| Wu, MH | 1 |
| Tsai, MM | 2 |
| Lin, TP | 1 |
| Yeh, YH | 1 |
| Park, HJ | 1 |
| Kim, J | 1 |
| Han, EJ | 1 |
| Park, SE | 1 |
| Park, CY | 1 |
| Lee, WY | 1 |
| Oh, KW | 1 |
| Park, SW | 1 |
| Rhee, EJ | 1 |
| Sharma, S | 1 |
| Dabla, PK | 1 |
| Kumar, M | 1 |
| Silva, MH | 1 |
| Araujo, MC | 1 |
| Diniz, EM | 1 |
| Ceccon, ME | 1 |
| Carvalho, WB | 1 |
| Vita, R | 1 |
| Lapa, D | 1 |
| Trimarchi, F | 1 |
| Vita, G | 1 |
| Fallahi, P | 1 |
| Antonelli, A | 1 |
| Benvenga, S | 1 |
| Fan, J | 1 |
| Yan, P | 1 |
| Wang, Y | 1 |
| Shen, B | 1 |
| Ding, F | 1 |
| Liu, Y | 1 |
| Chen, SL | 1 |
| Chuang, WY | 1 |
| Sun, CP | 1 |
| Askari, A | 1 |
| Ehrampoush, E | 1 |
| Homayounfar, R | 1 |
| Bahramali, E | 1 |
| Farjam, M | 1 |
| Feitosa, DS | 1 |
| Marques, MR | 1 |
| Casati, MZ | 1 |
| Sallum, EA | 1 |
| Nociti, FH | 1 |
| de Toledo, S | 1 |
| Iacoviello, M | 1 |
| Guida, P | 1 |
| Guastamacchia, E | 1 |
| Triggiani, V | 1 |
| Forleo, C | 1 |
| Catanzaro, R | 1 |
| Cicala, M | 1 |
| Basile, M | 1 |
| Sorrentino, S | 1 |
| Favale, S | 1 |
| Song, SH | 2 |
| Kwak, IS | 1 |
| Lee, DW | 1 |
| Kang, YH | 1 |
| Seong, EY | 1 |
| Park, JS | 1 |
| Vaurs-Barrière, C | 1 |
| Deville, M | 1 |
| Sarret, C | 1 |
| Giraud, G | 1 |
| Des Portes, V | 1 |
| Prats-Viñas, JM | 1 |
| De Michele, G | 1 |
| Dan, B | 1 |
| Brady, AF | 1 |
| Boespflug-Tanguy, O | 1 |
| Touraine, R | 1 |
| Díez, JJ | 1 |
| Iglesias, P | 1 |
| Saccà, L | 1 |
| Lubrano, V | 1 |
| Pingitore, A | 1 |
| Carpi, A | 1 |
| Iervasi, G | 1 |
| Lu, C | 1 |
| Zhao, L | 1 |
| Ying, H | 1 |
| Willingham, MC | 1 |
| Cheng, SY | 1 |
| Bertalan, R | 1 |
| Sallai, A | 1 |
| Sólyom, J | 1 |
| Lotz, G | 1 |
| Szabó, I | 1 |
| Kovács, B | 1 |
| Szabó, E | 1 |
| Patócs, A | 1 |
| Rácz, K | 1 |
| Jain, G | 1 |
| Devpura, G | 1 |
| Gupta, BS | 1 |
| Wasniewska, M | 1 |
| Corrias, A | 1 |
| Arrigo, T | 1 |
| Lombardo, F | 1 |
| Salerno, M | 1 |
| Mussa, A | 1 |
| Vigone, MC | 1 |
| De Luca, F | 1 |
| Rosario, PW | 1 |
| Vadiveloo, T | 1 |
| Donnan, PT | 1 |
| Cochrane, L | 1 |
| Leese, GP | 1 |
| Pantalone, KM | 1 |
| Nasr, C | 1 |
| Yang, JW | 1 |
| Han, ST | 1 |
| Kim, MK | 1 |
| Kim, JS | 1 |
| Choi, SO | 1 |
| Han, BG | 1 |
| Carlé, A | 1 |
| Bülow Pedersen, I | 1 |
| Knudsen, N | 1 |
| Perrild, H | 1 |
| Ovesen, L | 1 |
| Rasmussen, LB | 1 |
| Jørgensen, T | 1 |
| Laurberg, P | 1 |
| Pirnat, E | 1 |
| Fidler, V | 1 |
| Zaletel, K | 1 |
| Gaberscek, S | 1 |
| Hojker, S | 1 |
| Minakawa, M | 1 |
| Takeuchi, K | 1 |
| Ito, K | 1 |
| Tsushima, T | 1 |
| Fukui, K | 1 |
| Takaya, S | 1 |
| Fukuda, I | 1 |
| Telkova, IL | 1 |
| Tepliakov, AT | 1 |
| Heureux, M | 1 |
| Corvilain, B | 1 |
| Shimizu, Y | 1 |
| Masuda, S | 1 |
| Nishihara, K | 1 |
| Ji, L | 1 |
| Okuda, M | 1 |
| Inui, K | 1 |
| Piccoli, GB | 1 |
| Mezza, E | 1 |
| Burdese, M | 1 |
| Terzolo, M | 1 |
| Grassi, G | 1 |
| Bermond, F | 1 |
| Soragna, G | 1 |
| Gai, M | 1 |
| Dani, F | 1 |
| Jeantet, A | 1 |
| Segoloni, GP | 1 |
| Piccoli, G | 1 |
| Woeber, KA | 1 |
| Gurleyik, E | 1 |
| Coskun, O | 1 |
| Aslaner, A | 1 |
| Nielsen, VE | 1 |
| Bonnema, SJ | 1 |
| Boel-Jørgensen, H | 1 |
| Grupe, P | 1 |
| Hegedüs, L | 1 |
| Pinelli, M | 1 |
| Bindi, M | 1 |
| Cassetti, G | 1 |
| Moroni, F | 1 |
| Pandolfo, C | 1 |
| Rosada, J | 1 |
| Castiglioni, M | 1 |
| Witzke, O | 1 |
| Wiemann, J | 1 |
| Patschan, D | 1 |
| Wu, K | 1 |
| Philipp, T | 1 |
| Saller, B | 1 |
| Mann, K | 1 |
| Reinhardt, W | 1 |
| Ferguson, DC | 1 |
| Caffall, Z | 1 |
| Hoenig, M | 1 |
| Miyauchi, A | 1 |
| Takamura, Y | 1 |
| Ito, Y | 1 |
| Miya, A | 1 |
| Kobayashi, K | 1 |
| Matsuzuka, F | 1 |
| Amino, N | 1 |
| Toyoda, N | 1 |
| Nomura, E | 1 |
| Nishikawa, M | 1 |
| David, E | 1 |
| Rosen, IB | 1 |
| Bain, J | 1 |
| James, J | 1 |
| Kirsh, JC | 1 |
| Rogister, B | 1 |
| Belachew, S | 1 |
| Moonen, G | 1 |
| Huber, G | 1 |
| Guglielmetti, M | 1 |
| Huber, P | 1 |
| Kunz, M | 1 |
| Roth, CB | 1 |
| Staub, JJ | 1 |
| Nakae, T | 1 |
| Kawanaka, M | 1 |
| Suehiro, M | 1 |
| Sugita, M | 1 |
| Fukuchi, M | 1 |
| Franzese, A | 1 |
| Buono, P | 1 |
| Mascolo, M | 1 |
| Leo, AL | 1 |
| Valerio, G | 1 |
| Chantelau, E | 1 |
| Al-Abadi, AC | 1 |
| Feldkamp, J | 1 |
| Pascher, E | 1 |
| Schott, M | 1 |
| Goretzki, P | 1 |
| Seissler, J | 1 |
| Scherbaum, WA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pretreatment With Recombinant Human Thyrotropin (rhTSH) for the Effect on Thyroid Size and Function, and for the Effect of Radioiodine Treatment in Patients With Nodular Goiter. Prospective, Randomized Double-blinded Trials.[NCT00145366] | Phase 2 | 110 participants | Interventional | 2002-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for triiodothyronine and Disease Exacerbation
| Article | Year |
|---|---|
The Management of Thyroid Abnormalities in Chronic Heart Failure.
Topics: Disease Management; Disease Progression; Heart Failure; Hormone Replacement Therapy; Humans; Thyroid | 2019 |
Heart failure as a multiple hormonal deficiency syndrome.
Topics: Animals; Disease Progression; Exercise Tolerance; Heart; Heart Failure; Hormones; Humans; Insulin Re | 2009 |
Approach to a low TSH level: patience is a virtue.
Topics: Adult; Chorionic Gonadotropin; Disease Progression; Euthyroid Sick Syndromes; Female; Humans; Hypert | 2010 |
Mechanisms in endocrinology: Heart failure and thyroid dysfunction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; | 2012 |
[Subclinical hypothyroidism].
Topics: Biomarkers; Disease Progression; Humans; Hypothyroidism; Thyrotropin; Thyroxine; Triiodothyronine | 2004 |
Oligodendrocytes: from development to demyelinated lesion repair.
Topics: Cell Differentiation; Demyelinating Diseases; Disease Progression; Humans; Nerve Regeneration; Oligo | 1999 |
Subclinical thyrotoxicosis.
Topics: Cardiovascular Diseases; Diagnosis, Differential; Disease Progression; Humans; Hyperthyroidism; Oste | 2001 |
3 trials available for triiodothyronine and Disease Exacerbation
| Article | Year |
|---|---|
Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic adenoma.
Topics: Adenoma; Adult; Aged; Disease Progression; Female; Humans; Interleukin-6; Iodine Radioisotopes; Male | 2002 |
Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial.
Topics: Adult; Aged; Antithyroid Agents; Disease Progression; Dose-Response Relationship, Drug; Double-Blind | 2006 |
Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease.
Topics: Adult; Apoptosis; Disease Progression; fas Receptor; Female; Graves Disease; Humans; Hyperthyroidism | 2001 |
48 other studies available for triiodothyronine and Disease Exacerbation
| Article | Year |
|---|---|
The Frequency of Intrathyroidal Follicular Helper T Cells Varies with the Progression of Graves' Disease and Hashimoto's Thyroiditis.
Topics: Adult; Autoantibodies; Biomarkers; Disease Progression; Female; Graves Disease; Hashimoto Disease; H | 2022 |
A model of the cost of delaying treatment of Hashimotos thyroiditis: thyroid cancer initiation and growth.
Topics: Biopsy, Fine-Needle; Computer Simulation; Disease Progression; Hashimoto Disease; Humans; Hypothalam | 2019 |
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.
Topics: Aged; Animals; Anticarcinogenic Agents; Carcinogenesis; Carcinoma, Hepatocellular; Cell Differentiat | 2020 |
Clinical observation and analysis of thyroid hormone levels in patients with idiopathic membranous nephropathy.
Topics: Adult; Analysis of Variance; Case-Control Studies; Cholesterol, LDL; Disease Progression; Female; Fo | 2020 |
Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression.
Topics: Adult; Autoantibodies; Disease Progression; Drug Therapy, Combination; Female; Hashimoto Disease; Hu | 2020 |
Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Disea | 2020 |
Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy.
Topics: Animals; Cardiomyopathy, Dilated; Disease Models, Animal; Disease Progression; Iodide Peroxidase; Mi | 2017 |
The significance of TRIP11 and T3 signalling pathway in renal cancer progression and survival of patients.
Topics: Aryl Hydrocarbon Receptor Nuclear Translocator; Carcinoma, Renal Cell; Cell Line, Tumor; Cytoskeleta | 2017 |
Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women.
Topics: Alanine Transaminase; Cross-Sectional Studies; Disease Progression; Female; Humans; Liver Cirrhosis, | 2019 |
Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4.
Topics: Animals; Carcinoma, Hepatocellular; Cell Movement; Disease Progression; Humans; Intercellular Signal | 2013 |
The natural course of Hashimoto's thyroiditis in children and adolescents.
Topics: Adolescent; Child; Disease Progression; Female; Hashimoto Disease; Humans; Hypothyroidism; Male; Ret | 2014 |
Repression of microRNA-130b by thyroid hormone enhances cell motility.
Topics: Aged; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Disease Progression; Down-Regulati | 2015 |
Association of low baseline free thyroxin levels with progression of coronary artery calcification over 4 years in euthyroid subjects: the Kangbuk Samsung Health Study.
Topics: Adult; Aged; Coronary Artery Disease; Disease Progression; Euthyroid Sick Syndromes; Female; Humans; | 2016 |
Evaluation of Thyroid Hormone Status in Children with Steroid Resistant Nephrotic Syndrome: A North India Study.
Topics: Asymptomatic Diseases; Child; Child, Preschool; Creatinine; Cross-Sectional Studies; Disease Progres | 2015 |
Nonthyroidal illnesses syndrome in full-term newborns with sepsis.
Topics: Disease Progression; Euthyroid Sick Syndromes; Humans; Infant; Infant, Newborn; Sepsis; Shock, Septi | 2015 |
Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.
Topics: Age of Onset; Alleles; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Genetic Assoc | 2017 |
Prevalence and Clinical Significance of Low T3 Syndrome in Non-Dialysis Patients with Chronic Kidney Disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Cross-Sectional Studies; Disease Progression; Female; Glomerula | 2016 |
Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy.
Topics: Animals; Autophagy; Carcinogenesis; Carcinoma, Hepatocellular; Death-Associated Protein Kinases; Die | 2016 |
Serum insulin in pathogenesis and treatment of osteoarthritis.
Topics: Adipokines; Cartilage; Cell Differentiation; Cell Proliferation; Chondrocytes; Disease Progression; | 2017 |
The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats.
Topics: Acid Phosphatase; Alveolar Bone Loss; Alveolar Process; Animals; Biomarkers; Bone Density; Disease P | 2009 |
Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients.
Topics: Aged; Chronic Disease; Disease Progression; Echocardiography; Electrocardiography; Female; Follow-Up | 2008 |
The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone.
Topics: Adult; Aged; Biomarkers; Chronic Disease; Disease Progression; Female; Glomerular Filtration Rate; H | 2009 |
Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.
Topics: Brain; Child; Disease Progression; DNA Mutational Analysis; Exons; Family Health; Follow-Up Studies; | 2009 |
An analysis of the natural course of subclinical hyperthyroidism.
Topics: Aged; Disease Progression; Female; Humans; Hyperthyroidism; Kaplan-Meier Estimate; Male; Middle Aged | 2009 |
Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure.
Topics: Adult; Aged; C-Reactive Protein; Disease Progression; Female; Heart Failure; Humans; Inflammation; I | 2010 |
Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Animals; Blotting, Western; Cell Proliferation; Disease Models, Animal; | 2010 |
Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy.
Topics: Adolescent; Arnold-Chiari Malformation; Child; Disease Progression; Genome; Germ-Line Mutation; Huma | 2010 |
Abnormalities in the thyroid function tests as surrogate marker of advancing HIV infection in infected adults.
Topics: Adult; Biomarkers; CD4 Lymphocyte Count; Disease Progression; Epidemiologic Methods; Female; HIV Inf | 2009 |
Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease.
Topics: Adolescent; Autoantibodies; Child; Disease Progression; Female; Graves Disease; Hashimoto Disease; H | 2010 |
Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study.
Topics: Aged; Disease Progression; Female; Follow-Up Studies; Humans; Hyperthyroidism; Middle Aged; Predicti | 2010 |
The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Databases, Factual; Disease Progression; Female; Humans; | 2011 |
Serum T3 level can predict cardiovascular events and all-cause mortality rates in CKD patients with proteinuria.
Topics: Biomarkers; Cardiovascular Diseases; Cause of Death; Disease Progression; Female; Follow-Up Studies; | 2012 |
Graves' hyperthyroidism and moderate alcohol consumption: evidence for disease prevention.
Topics: Adult; Alcohol Drinking; Anti-Infective Agents, Local; Case-Control Studies; Denmark; Disease Progre | 2013 |
Restoration of sarcoplasmic reticulum protein level by thyroid hormone contributes to partial improvement of myocardial function, but not to glucose metabolism in an early failing heart.
Topics: Animals; Calcium-Transporting ATPases; Cells, Cultured; Disease Models, Animal; Disease Progression; | 2003 |
[Changes of thyroid hormone levels in the progression of coronary arteriosclerosis].
Topics: Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Disease Progression; Heart Fail | 2004 |
Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats.
Topics: Animals; Blotting, Western; Ceftibuten; Cephalosporins; Dipeptides; Disease Progression; In Vitro Te | 2005 |
Progression of renal failure without proteinuria in a patient with type 1 diabetes.
Topics: Adult; Biopsy; Creatine Kinase; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progressi | 2004 |
Observations concerning the natural history of subclinical hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Follow-Up Studies; Goiter, Nodular; Gra | 2005 |
Clinical importance of solitary solid nodule of the thyroid in endemic goiter region.
Topics: Adult; Aged; Biomarkers; Biopsy, Fine-Needle; Diagnosis, Differential; Disease Progression; Female; | 2005 |
Relationship between low T3 syndrome and NT-proBNP levels in non-cardiac patients.
Topics: Aged; Disease Progression; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Peptide | 2007 |
Differential T4 degradation pathways in young patients with preterminal and terminal renal failure.
Topics: Acute Kidney Injury; Adult; Cohort Studies; Diet; Disease Progression; Female; Humans; Iodine; Kidne | 2007 |
Obesity increases free thyroxine proportionally to nonesterified fatty acid concentrations in adult neutered female cats.
Topics: Animals; Cats; Diabetes Mellitus, Type 2; Disease Progression; Fatty Acids, Nonesterified; Female; I | 2007 |
3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Iod | 2008 |
Management of the hot thyroid nodule.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; D | 1995 |
[Functional dynamics of impending overt hypothyroidism: spontaneous evolution in patients in the years before the beginning of treatment].
Topics: Analysis of Variance; Biomarkers; Disease Progression; Female; Humans; Hypothyroidism; Thyrotropin; | 1999 |
Plummer's disease with spontaneous progression to hypothyroidism.
Topics: Autoantibodies; Disease Progression; Female; Goiter, Nodular; Humans; Hypothyroidism; Middle Aged; R | 1999 |
Thyroid autoimmunity starting during the course of type 1 diabetes denotes a subgroup of children with more severe diabetes.
Topics: Adolescent; Autoantibodies; Child; Child, Preschool; Diabetes Mellitus, Type 1; Disease Progression; | 2000 |
Possible activation of auto-immune thyroiditis from continuous subcutaneous infusion of genapol-containing insulin.
Topics: Autoantibodies; Chemistry, Pharmaceutical; Diabetes Mellitus, Type 1; Disease Progression; Female; H | 2000 |